Greg Hussack

100 Sussex Drive, K1A 0R6
Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

Journal: Science translational medicine

Published: May 13, 2026

A Safe and Accessible Cell-Based Spike-ACE2 Binding Assay for Evaluating SARS-CoV-2 Neutralization Activity in Biological Samples Using Flow Cytometry.

A Safe and Accessible Cell-Based Spike-ACE2 Binding Assay for Evaluating SARS-CoV-2 Neutralization Activity in Biological Samples Using Flow Cytometry.

Journal: Methods and protocols

Published: July 15, 2025

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target.

Journal: Cell reports. Medicine

Published: January 09, 2025

Structure of the Fab fragment of a humanized 5E5 antibody to a cancer-specific Tn-MUC1 epitope.

Structure of the Fab fragment of a humanized 5E5 antibody to a cancer-specific Tn-MUC1 epitope.

Journal: Acta crystallographica. Section D, Structural biology

Published: December 06, 2024

Editorial: Single-domain antibodies-biology, engineering and emerging applications, volume II.

Editorial: Single-domain antibodies-biology, engineering and emerging applications, volume II.

Journal: Frontiers in immunology

Published: November 29, 2024

Optimization of synthetic human VH affinity and solubility through in vitro affinity maturation and minimal camelization.

Optimization of synthetic human VH affinity and solubility through in vitro affinity maturation and minimal camelization.

Journal: Protein science : a publication of the Protein Society

Published: November 27, 2024

Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells.

Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells.

Journal: Antibody therapeutics

Published: November 21, 2024

In vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats.

In vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats.

Journal: Fluids and barriers of the CNS

Published: November 06, 2024

A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.

A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 17, 2024

Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6.

Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6.

Journal: Molecular cancer therapeutics

Published: December 07, 2023

Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.

Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.

Journal: Applied microbiology and biotechnology

Published: November 03, 2023

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.

Journal: Molecular therapy. Oncology

Published: September 29, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026